NEWMarkets

KalVista (KALV) CEO Sells $193,065 in Company Stock

Published on 4/20/2026

#KALV#insiderTrading#stockSale
KalVista (KALV) CEO Sells $193,065 in Company Stock

AI Summary

KalVista Pharmaceuticals' CEO, Benjamin Palleiko, sold $193,065 worth of company stock. This transaction may raise concerns among investors regarding the CEO's confidence in the company's future prospects. The stock sale's timing and implications for shareholder value can affect market perceptions. Monitoring such insider transactions can provide insights into future price movements for KalVista (KALV).

Source: Read original article (opens in new tab)

Related News

Singapore Dollar (SGD) Weakens Slightly Amid U.S.-Iran Talks
Markets

Singapore Dollar (SGD) Weakens Slightly Amid U.S.-Iran Talks

Apr 21

Activist investors gain traction in Japan's markets
Markets

Activist investors gain traction in Japan's markets

Apr 21

Indian Stocks Face Fuel Price Hike Risk Amidst Market Concerns
Markets

Indian Stocks Face Fuel Price Hike Risk Amidst Market Concerns

Apr 21

MSCI Delays Indonesia Review Amid Downgrade Fears Affecting Investors
Markets

MSCI Delays Indonesia Review Amid Downgrade Fears Affecting Investors

Apr 21